614 related articles for article (PubMed ID: 33463457)
1. Polycystic Ovary Syndrome: A Contemporary Clinical Approach.
Bjekić-Macut J; Vukašin T; Velija-Ašimi Z; Bureković A; Zdravković M; Andrić Z; Branković M; Crevar-Marinović S; Madić T; Stanojlović O; Milutinović DV; Livadas S; Mastorakos G
Curr Pharm Des; 2021; 27(36):3812-3820. PubMed ID: 33463457
[TBL] [Abstract][Full Text] [Related]
2. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of GLP-1 on anthropometrics, metabolic and endocrine parameters in patients with PCOS.
Bader S; Bhatti R; Mussa B; Abusanana S
Womens Health (Lond); 2024; 20():17455057241234530. PubMed ID: 38444070
[TBL] [Abstract][Full Text] [Related]
4. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).
Siddiqui S; Mateen S; Ahmad R; Moin S
J Assist Reprod Genet; 2022 Nov; 39(11):2439-2473. PubMed ID: 36190593
[TBL] [Abstract][Full Text] [Related]
5. Polycystic Ovary Syndrome.
Azziz R
Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
[TBL] [Abstract][Full Text] [Related]
6. Polycystic ovary syndrome: reviewing diagnosis and management of metabolic disturbances.
Spritzer PM
Arq Bras Endocrinol Metabol; 2014 Mar; 58(2):182-7. PubMed ID: 24830595
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
Zhao H; Xing C; Zhang J; He B
Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
[TBL] [Abstract][Full Text] [Related]
8. Insulin-sensitizing agents for infertility treatment in woman with polycystic ovary syndrome: a narrative review of current clinical practice.
Sparić R; Andjić M; Rakić A; Bjekić-Macut J; Livadas S; Kontić-Vučinić O; Mastorakos G; Macut D
Hormones (Athens); 2024 Mar; 23(1):49-58. PubMed ID: 37792213
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.
Zeng X; Xie YJ; Liu YT; Long SL; Mo ZC
Clin Chim Acta; 2020 Mar; 502():214-221. PubMed ID: 31733195
[TBL] [Abstract][Full Text] [Related]
10. Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?
Cheang KI; Nestler JE
Reprod Biomed Online; 2004 Apr; 8(4):440-7. PubMed ID: 15149568
[TBL] [Abstract][Full Text] [Related]
11. Drug insight: insulin-sensitizing drugs in the treatment of polycystic ovary syndrome--a reappraisal.
Dunaif A
Nat Clin Pract Endocrinol Metab; 2008 May; 4(5):272-83. PubMed ID: 18364705
[TBL] [Abstract][Full Text] [Related]
12. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis.
Naderpoor N; Shorakae S; de Courten B; Misso ML; Moran LJ; Teede HJ
Hum Reprod Update; 2015; 21(5):560-74. PubMed ID: 26060208
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Bushen Huatan Decoction combined with Baduanjin in the treatment of polycystic ovary syndrome with insulin resistance (IR-PCOS), kidney deficiency and phlegm dampness: study protocol for a randomized controlled trial.
Qian H; Xu W; Cui L; Wang R; Wang J; Tang M; Wei M; Wang L
Trials; 2021 Nov; 22(1):781. PubMed ID: 34743745
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic effects of glucagon-like peptide-1 receptor agonists and metformin on polycystic ovary syndrome: A protocol for systematic review and meta-analysis.
Ma R; Ding X; Wang Y; Deng Y; Sun A
Medicine (Baltimore); 2021 Jun; 100(23):e26295. PubMed ID: 34115034
[TBL] [Abstract][Full Text] [Related]
15. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
Sanchez-Garrido MA; Tena-Sempere M
Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
[TBL] [Abstract][Full Text] [Related]
16. Insulin-sensitisers in the treatment of polycystic ovary syndrome.
Teede HJ; Meyer C; Norman RJ
Expert Opin Pharmacother; 2005 Nov; 6(14):2419-27. PubMed ID: 16259573
[TBL] [Abstract][Full Text] [Related]
17. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
18. Metformin therapy improves ovulatory rates, cervical scores, and pregnancy rates in clomiphene citrate-resistant women with polycystic ovary syndrome.
Kocak M; Caliskan E; Simsir C; Haberal A
Fertil Steril; 2002 Jan; 77(1):101-6. PubMed ID: 11779598
[TBL] [Abstract][Full Text] [Related]
19. Nonalcoholic Fatty Liver Disease in Patients with Polycystic Ovary Syndrome.
Macut D; Bjekić-Macut J; Livadas S; Stanojlović O; Hrnčić D; Rašić-Marković A; Milutinović DV; Mladenović V; Andrić Z
Curr Pharm Des; 2018; 24(38):4593-4597. PubMed ID: 30652641
[TBL] [Abstract][Full Text] [Related]
20. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]